Sickle Cell Anemia

	07/28/2009	Study of PAH Treatment in Patients With Sickle Cell Disease Halted Due to Safety Concerns - (DGNews)
	12/11/2008	Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy (JAMA)
	08/11/2008	New Test Measures Hepcidin, Can Help Diagnose Anaemias and Iron Disorders - (DGNews)
	08/06/2008	Single Lot of Epoetin Alfa Recalled Due to Damaged Vials - (DGNews)
	02/28/2008	NIH: Hydroxyurea Is Underused for Sickle Cell Disease - (DGNews)
	01/25/2008	Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection (JAMA)
	12/11/2007	Adults With Sickle Cell Disease Have Significant Cognitive Impairment: Presented at ASH - (DGDispatch)
	07/12/2007	Network Model Predicts Risk of Death in Sickle Cell Disease - (DGNews)
	05/02/2007	Serious Illness Among Children With Sickle Cell Disease Reduced With Vaccine - (DGNews)
	01/29/2007	Risk for Stroke, Death Not Higher for Sickle Cell Children With Early Complications - (DGNews)
	09/21/2006	Exjade (Deferasirox), a Breakthrough Once-Daily Oral Iron Chelator, Now Available in the UK - (DGNews)
	09/12/2006	Iron Overload is Common in Sickle Cell Disease and Should be Managed - (DGDispatch)
	09/12/2006	STOP Trials Demonstrated Value of Chronic Blood Transfusion to Prevent Stroke in Children With Sickle Cell Disease - (DGDispatch)
	09/12/2006	Management of Iron Overload in Patients With Sickle Cell Disease - (DGDispatch)
	09/12/2006	Global Sickle Cell Disease Guidelines Must Address Wide Range of Challenges for Success, Expert Says - (DGDispatch)
	09/12/2006	Oral Iron Chelator Shown to be Safe and Effective for Treating Iron Overload in Patients With Sickle Cell Anemia - (DGDispatch)
	07/22/2006	Blood Test Predicts Common and Severe Complication of Sickle Cell Disease, and Identifies Patients at Highest Risk of Death - (DGNews)
	06/06/2006	Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF - (DGNews)
	05/01/2006	Male Diabetics with Asymptomatic Sickle Cell Traits Face Magnified Risk of Complications: Presented at AACE - (DGDispatch)
	04/03/2006	Sickle Cell Patients Frequently Develop Obstructive Sleep Apnea: Presented at AAN - (DGDispatch)
	01/03/2006	Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease (N Engl J Med)
	12/29/2005	Stroke Risk Returns when Children with Sickle Cell Disease Stop Transfusions - (DGNews)
	12/13/2005	Biomarker May Predict Risk Factor in Sickle Cell Patients: Presented at ASH - (DGDispatch)
	11/03/2005	Exjade, a Breakthrough Once-Daily Oral Iron Chelator, Receives First Approval Worldwide in the U.S. - (DGNews)
	05/27/2005	Polyglandular Autoimmune Syndrome in a Patient With Sickle Cell Anemia: Presented at AACE - (DGDispatch)
	02/16/2005	Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning Regime Promising Treatment for Sickle Cell Disease: Presented at ASBMT - (DGDispatch)
	12/17/2004	Children With Sickle Cell At High Risk of Stroke Need Continued Transfusions: Presented at ASH - (DGDispatch)
	12/08/2004	Bone Marrow Transplantation Suitable for Sickle Cell Disease: Presented at ASH - (DGDispatch)
	12/07/2004	Sildenafil Has Favorable Impact on Pulmonary Hypertension in Sickle Cell Disease: Presented at ASH - (DGDispatch)
	12/06/2004	New Blocker of Gardos Channel Improves Red Blood Cell Survival in Sickle Cell Anemia: Presented at ASH - (DGDispatch)